NavamedicASA (Navamedic) is a Norwegian pharmaceutical company that inlicenses and/ or buys and markets pharmaceuticals and other health care products in northern Europe. The product portfolio includes original and generic pharmaceuticals as well as food supplements, medical devices and other health care products. Navamedic market products from a large number of companies not self represented on the markets served by Navamedic.
Navamedic, established in 2002, consists of Navamedic ASA and the 100% owned
subsidiary Vitaflo Scandinavia AB in Sweden and the 100% owned subsidiary Navamedic efh, Island. Navamedic has its head office in Lysaker, Oslo. Navamedic has been listed on Oslo Stock Exchange since 2006.
Vitaflo Scandinavia AB was established in 1999 and became a part of the Navamedic
group in 2007. Vitaflo focuses on inlicensing and buying pharmaceuticals and other health care products within a few selected knowledge areas. Vitaflo has sales and distribution in Norway, Sweden, Denmark, Finland and the Netherlands as well as some additional export markets.
Navamedic is presently building a business around the sales and marketing of generic pharmaceuticals targeted towards the Nordic and BeNeLux markets. This business unit is built upon the cooperation with the South African pharmaceutical company Aspen Healthcare. Aspen Healthcare, with its corporate head quarters in Johannesburg, is one of the worlds 8 largest producers of generic pharmaceuticals with a turn over of more than NOK 10 billion. The agreement with Aspen assures Navamedic a broad portfolio of new products to register and market in the selected territories.
Long term vision Nordic and Benelux
One of 5 in 2015. One of 3 2020.
More quality in life - for less money